CXCL8 and inflammatory bowel disease: Moreover, the decrease in IL-8 and its transcriptional inhibition is a key step in IBD patients because the release of IL-8 from colon epithelial cells can contribute to the pathological process of gastrointestinal inflammation and malignancies [69].